HCVC Analysis
What is HCVC?
HCVC is a venture capital firm that supports founders addressing complex scientific and technological challenges. They provide capital, resources, and collaboration opportunities to help these founders succeed. The firm focuses on industrializing scientific advancements and technological progress.
Location
59 Rue Beaubourg, Paris, Île-de-France 75003, France
Employees
11-50
Founded
2015
Headquarter Location
France
Notable Portfolio Companies
Dyna Robotics, Lendurai, Kyron.bio, Cosmic Robotics, Chef
Recent Investment Announcements
- kyron.bio: HCVC leads a €5.5M round to use glycan engineering for advanced drug design. Read More (May 28, 2025)
- Fuse Vectors: Secures over €4.9 million for gene therapy with its cell-free viral vector technology, led by HCVC. Read More (Feb 25, 2025)
- Fuse Vectors: Raises $5.2 million in pre-seed financing led by HCVC for its cell-free viral vector technology. Read More (Feb 25, 2025)
- HCVC: Announced the final closing of its second fund of $75 million aimed at investing in deep tech startups. Read More (Oct 3, 2023)
Investment Thesis
HCVC's investment thesis focuses on supporting early-stage companies that are engaged in automating and digitizing the physical world. They prioritize investments in both software and hardware-based products, provided these companies can establish long-term competitive advantages through technical defensibility. HCVC aims to partner with founders who are tackling complex scientific and technological challenges, offering not just capital but also resources and collaboration opportunities to help these entrepreneurs succeed.
See something that needs updating? Suggest edits to this profile.